Green book 3 Flashcards
Which of the following statements is/are true regarding Hepatitis B infection:
a) Infection results in jaundice in greater than 50% of all cases
b) The incubation period ranges from 14-60 days
c) Chronic disease is strongly linked to the development of liver cancer
d) Less that half of children infected per-natally develop chronic disease
e) Most of those infected as adults will become chronic carriers of HBV
Chronic disease is strongly linked to the development of liver cancer
Hepatitis B vaccines:
a) Are not effective in patients with acute hepatitis B
b) Are live attenuated vaccines
c) Fewer than 10% of adults fail to respond to hep B vaccines adequately
d) Are very effective if used for post-exposure prophylaxis
e) Work best in those aged over 40 years
Are not effective in patients with acute hepatitis B
Fewer than 10% of adults fail to respond to hep B vaccines adequately
Are very effective if used for post-exposure prophylaxis
Hepatitis B vaccines:
a) Contain hepatitis B core antigen prepared from yeast cells
b) All contain the same dosage
c) Should not be given to a person who may already have been exposed to Hepatitis B
without checking for markers of past infection
d) Should not be administered into the buttock
e) Induce anti-HBs specific antibodies
Are interchangeable (different vaccines can be used to complete a primary course)
Should not be administered into the buttock
Induce anti-HBs specific antibodies
Which of the following people should receive pre-exposure Hepatitis B vaccine:
a) Healthcare workers (including students/trainees) working in the UK
b) Staff working in residential accommodation for people with learning difficulties
c) Embalmers
d) Prison officers
e) Laboratory staff handling materials which may contain the virus
Healthcare workers (including students/trainees) working in the UK
Staff work at residential accommodation for people with learning difficulties
Embalmers
Prison officers
Laboratory staff handling materials which may contain the virus
Which of the following should receive pre-exposure Hepatitis B vaccine:
a) Short term foster carers
b) Sewage workers
c) People receiving regular blood transfusions
d) People with chronic liver disease
e) People with chronic renal disease
Short term foster carers
People receiving regular blood transfusions
People with chronic liver disease
People with chronic renal disease
Which of the following should receive pre-exposure Hepatitis B vaccine:
a) People living in residential accommodation with learning disabilities
b) Prison inmates
c) Intra-venous drug users
d) Household contacts of people who inject drugs
e) People who work with primates
People living in residential accommodation with learning disabilities
Prison in mates
Intravenous drug users
Household contacts of people who inject drugs
Post-exposure prophylaxis with HBIG is recommended for:
a) Non-responders to hep B vaccine who have had a needle stick injury from a patient
with acute hepatitis B
b) People who have had unprotected sexual intercourse with a case of acute of
hepatitis B seen within one week of last contact
c) Babies born to women with chronic hepatitis B infection who are e antigen positive
d) People who have had unprotected sexual intercourse with a recently diagnosed case
of chronic hepatitis B 2 weeks ago
e) Babies born to women who have developed acute hepatitis B infection during
pregnancy
Non-responders to hep B vaccine who have had a needle stick injury from a patient with acute hepatitis B
People who have had unprotected sexual intercourse with a case of acute of hepatitis B seen within one week of last contact
Babies born to women with chronic hepatitis B infection who are e antigen positive
Babies born to women who have developed acute hepatitis B infection during pregnancy
Available pre-exposure hepatitis B immunisation schedules for high risk exposure in adults include: a) 0, 1 month, 2 months and 12 months b) 0, 7 days, 21 days and 12 months c) 0, 1 month, 6 months and 12 months d) 0, 2 months, 6 months and 12 months e) 0, 2 months, 3 months and 4 months
0, 1 month, 2 months and 12 months
0, 7 days, 21 days and 12 months
An immunocompetent healthcare worker is found to have an anti-HBs level of 10
– 100 mIU/ml after a course of hepatitis B vaccine. Which of the following is/are
true?
a) They need no further doses of hep B vaccine as satisfactory protection has been
achieved
b) They should have 1 further dose of hep B vaccine
c) They should have 1 further course of hep B vaccine
d) They should have single booster dose of hep B vaccine after 5 years
e) They should receive a booster dose of hep B vaccine every 5 years
They should have 1 further dose of hep B vaccine
They should have single booster dose of hep B vaccine after 5 years
The following is/are true of babies born to hep B positive mothers:
a) If the mother is HBsAg positive and HBeAg the baby should receive a dose of HBIG
at birth
b) If the mother is HBsAg positive, HBeAg negative and the baby weighs 1800g the
baby should receive HBIG
c) The first dose of hep B vaccine should be given within 24 hours of birth
d) They should be tested for HBsAg at 6 months of age
e) They should be tested for HBsAg at 12 months of age
If the mother is HBsAg positive and HBeAg the baby should receive a dose of HBIG at birth
The first dose of hep B vaccine should be given within 24 hours of birth
They should be tested for HBsAg at 12 months of age
Babies born after the 1st August 2017 in the UK whose mothers are NOT known to
be hep B carriers should receive:
a) Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
b) A booster dose of Hexavalent vaccine at 1 year
c) A blood test for HBsAg at 1 year
d) A pre-school booster dose of Hexavalent vaccine
e) A blood test to measure response to the hep B vaccine 2 months after completion of
the Hexavalent vaccine schedule
Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
A booster dose of Hexavalent vaccine at 1 year
Babies born after 1st August 2017 in the UK to hep B carrier mothers should
receive:
a) Doses of monovalent hep B vaccine at birth and 4 weeks
b) Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
c) A dose of Hexavalent vaccine at 1 year
d) A dose of monovalent hep B vaccine at 1 year
e) A pre-school booster dose of monovalent vaccine at 3 years 4 months
Doses of monovalent hep B vaccine at birth and 4 weeks
Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
A dose of monovalent hep B vaccine at 1 year
Which of the following should NOT be given Hepatitis B vaccine:
a) Those with a confirmed anaphylactic reaction to a previous dose of Hepatitis B
vaccine
b) Immunosuppressed individuals
c) Pregnant women
d) HIV positive people
e) Premature infants
Those with a confirmed anaphylactic reaction to a previous dose of Hepatitis B vaccine
The following is/are true about Human Papillomavirus (HPV) infection:
a) HPV 18 is responsible for more than 50 % of all cervical cancers in Europe
b) HPV types 6 and 11 cause the majority of genital warts
c) 90 % of new HPV infections clear within 2 years
d) Approximately 100 types of HPV infect the genital tract
e) HPV can be transmitted from mother to newborn baby
HPV types 6 and 11 cause the majority of genital warts
90 % of new HPV infections clear within 2 years
HPV can be transmitted from mother to new-born baby
The following is/are true about HPV vaccines:
a) They are contraindicated in yeast allergy
b) A 2-dose schedule should be given to those who are HIV infected or known to be
immunocompromised
c) They are given intramuscularly
d) Males and females in cohorts eligible for vaccination in the National Programme
remain so until their 25th birthday
e) If a course of HPV infection is interrupted it should be repeated
They are given intramuscularly
Males and females in cohorts eligible for vaccination in the National Programme remain so until their 25th birthday
The following is/are true about Gardasil:
a) It contains thiomersal
b) It contains HPV types 6,11,16 and 18
c) The minimum interval between 2 doses of Gardasil for children and adolescents
aged between 9 and below 15 years of age is 6 months
d) There is evidence on the interchangeability of Gardasil and Cervarix
e) If Gardasil is given at the same time as dTaP both vaccines can be given at the
same site
It contains HPV types 6,11,16 and 18
The minimum interval between 2 doses of Gardasil for children and adolescents aged between 9 and below 15 years of age is 6 months
The following is/are true about Cervarix:
a) It will provide protection against genital warts
b) If the 3-dose course is interrupted it should be resumed but not repeated
c) It is supplied as a suspension of virus-like particles(VLPs) in a pre-filled syringe
d) The risk of local reactions is less if given intramuscularly rather than subcutaneously
e) It contains HPV types 11 and 16
If the 3-dose course is interrupted it should be resumed but not repeated
It is supplied as a suspension of virus-like particles(VLPs) in a pre-filled syringe
It should be given by the intramuscular route
. In the UK, the groups recommended to receive HPV vaccine include(s):
a) Children aged 9-11 years
b) Adolescents aged 11-14 years
c) Older adolescents and adults aged 15-30 years
d) MSM aged up to and including 45 years
e) MSM aged 50 with no previous history of HPV vaccine
Adolescents aged 11-14 years
MSM aged up to and including 45 years
In the UK programme the following patient groups should not be routinely advised to receive HPV vaccine: a) Patients with immunosuppression b) Patients with HIV infection c) Patients who are pregnant d) Males aged 11-18 years e) Females coming to the UK from overseas under the age of 18 years with an uncertain immunisation history
Patients who are pregnant
Males aged 11-18 years
Which of the following is/are true:
a) Influenza is caused by type A, B or C viruses
b) Influenza A is the usual cause of epidemics
c) Minor changes in the surface antigens of influenza A occur every year
d) “Antigenic shift” means a major change in the influenza A virus has occurred
e) The burden of influenza B disease is mostly in adults
Influenza is caused by type A, B or C viruses
Influenza A is the usual cause of epidemics
Minor changes in the surface antigens of influenza A occur every year
“Antigenic shift” means a major change in the influenza A virus has occurred